ORIC Q1 2020 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ORICORIC Pharmaceuticals, Inc.

$1B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$250,000

Operating Income

-$9M

Net Income

-$9M

EPS (Diluted)

$-0.32

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$527,000

Balance Sheet

Total Assets

$85M

Total Liabilities

$183M

Stockholders' Equity

-$98M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$250,000	$0	—
Operating Income	-$9M	-$6M	-44.6%
Net Income	-$9M	-$6M	-47.5%